Agenovir Corporation engages in the research and development of anti-viral therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. It uses nucleases, including CRISPR/Cas9 to target viral DNA for disruption.
Agenovir Corporation
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.agenovir.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address499 Illinois Street, Suite 500 San Francisco, CA 094158CaliforniaUnited States
499 Illinois Street, Suite 500 San Francisco, CA 094158
California
United States
Contact Number650-491-9624
650-491-9624
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/agenovir-corporation” connections=”true” suffix=””]